A capital increase of €130 million for Huma. Hat stands as the sole Italian private equity investor in the venture.

Huma Therapeutics Limited, an international company specializing in healthcare technology that combines predictive care and machine learning, has announced the completion of a $130 million (approximately €107 million) capital increase. There is an option to approve an additional capital increase of $70 million (approximately €58 million) to be exercised in the future, which would bring the total capital raised to over $200 million (approximately €165 million). Huma was recently recognized by the Financial Times as the fastest-growing European healthcare company.